Aurobindo, Hetero, and Vivimed Class Action Settlements in New Jersey
Aurobindo, Hetero, and Vivimed class action settlements that covered New Jersey residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
New Jersey residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for New Jersey Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in New Jersey
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
New Jersey residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed have specific legal protections under the state's Consumer Fraud Act, which provides broader remedies than federal law. These pharmaceutical companies distributed millions of valsartan, losartan, and irbesartan tablets containing NDMA and NDEA carcinogens throughout New Jersey's extensive pharmacy networks. Aurobindo operates significant distribution channels serving New Jersey's dense population centers, while Hetero and Vivimed products reached consumers through major retail chains like CVS and Walgreens. New Jersey's courts have concurrent jurisdiction with federal court for these claims, meaning residents can potentially file in state court under more favorable consumer protection statutes. The $15.2 million settlement covers patients who purchased contaminated medications between 2012-2019. New Jersey residents don't need to prove individual harm to recover compensation, as the settlement recognizes the increased cancer risk from NDMA exposure. Filing deadlines are strictly enforced, and New Jersey residents must submit valid proof of purchase or prescription records to qualify for settlement payments.
Aurobindo, Hetero, and Vivimed Settlements in New Jersey: FAQs
Can New Jersey residents file claims for Aurobindo, Hetero, and Vivimed contaminated blood pressure medications under state consumer protection laws?
Yes, New Jersey's Consumer Fraud Act provides additional protections beyond federal remedies for residents who purchased contaminated valsartan, losartan, or irbesartan from these manufacturers. New Jersey residents can pursue claims in state court alongside or instead of federal class action settlements, potentially recovering treble damages under state law.
How much compensation can New Jersey residents receive from the $15.2 million Aurobindo, Hetero, and Vivimed settlement?
Settlement amounts vary based on the duration of contaminated medication use and specific manufacturer involved. New Jersey residents who used these medications for longer periods typically receive higher compensation, with payments ranging from $50 to several hundred dollars depending on individual exposure levels.
What documentation do New Jersey residents need to file claims against Aurobindo, Hetero, and Vivimed?
New Jersey residents must provide pharmacy records, prescription bottles, or insurance statements showing purchases of contaminated valsartan, losartan, or irbesartan between 2012-2019. CVS, Walgreens, and other major New Jersey pharmacy chains can provide historical purchase records if original documentation is unavailable.
Tips for New Jersey Residents Filing Aurobindo, Hetero, and Vivimed Claims
New Jersey residents filing claims against Aurobindo, Hetero, and Vivimed should gather all prescription records from 2012-2019 showing purchases of valsartan, losartan, or irbesartan. Contact your pharmacy directly for historical records if you lack documentation. Submit claims before deadlines expire, as New Jersey courts strictly enforce filing periods. Consider consulting attorneys familiar with New Jersey's Consumer Fraud Act for potential additional remedies beyond federal settlements. Keep copies of all submitted documentation and track claim status through settlement administrators. New Jersey residents may qualify for higher compensation under state consumer protection laws compared to federal class action recoveries.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
